Intellectual Property India Publishes Patent Application for 'Modulators Of Nlrp3 Inflammasome And Related Products And Methods' Filed by Neumora Therapeutics, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517060877 A) filed by Neumora Therapeutics, Inc., Watertown, U.S.A., on June 25, for 'modulators of nlrp3 inflammasome and related products and methods.'

Inventor(s) include Beausoleil, Anne-Marie; and Hudson, Ryan.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "Compounds are provided for inhibiting NLRP3 inflammasome generally, or for treating a NLRP3 inflammasome dependent condition more specifically, by contacting the NLRP3 inflammasome or administering to a subject in need thereof, respectively, an effective amount of a compound having str...